Cargando…

MAO-B Polymorphism Associated with Progression in a Chinese Parkinson's Disease Cohort but Not in the PPMI Cohort

INTRODUCTION: Genetic factors play an important role in Parkinson's disease (PD) risk. However, the genetic contribution to progression in Chinese PD patients has rarely been studied. This study investigated genetic associations with progression based on 30 PD risk loci common in a longitudinal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Shi-Shuang, Wu, Ling-Yu, Li, Gen, Du, Juan-Juan, Huang, Pei, Liu, Jin, Ling, Yun, Ren, Kang, Chen, Zhong-Lue, Chen, Sheng-Di
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509281/ https://www.ncbi.nlm.nih.gov/pubmed/36164437 http://dx.doi.org/10.1155/2022/3481102

Ejemplares similares

The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
por: Marek, Kenneth, et al.
Publicado: (2018)

Reference LINE-1 insertion polymorphisms correlate with Parkinson’s disease progression and differential transcript expression in the PPMI cohort
por: Fröhlich, Alexander, et al.
Publicado: (2023)

Blood Neurofilament Light Chain in Parkinson’s Disease: Comparability between Parkinson’s Progression Markers Initiative (PPMI) and Asian Cohorts
por: Chen, Jia-Hung, et al.
Publicado: (2021)

Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort
por: Eusebi, Paolo, et al.
Publicado: (2018)

Extrastriatal (123)I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
por: Nicastro, Nicolas, et al.
Publicado: (2020)

Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort
por: Mihaescu, Alexander S., et al.
Publicado: (2022)

Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort
por: Simuni, Tanya, et al.
Publicado: (2018)

Motor subtypes and clinical characteristics in sporadic and genetic Parkinson's disease groups: analysis of the PPMI cohort
por: Jeong, Eun Hye, et al.
Publicado: (2023)

Alteration of Tremor Dominant and Postural Instability Gait Difficulty Subtypes During the Progression of Parkinson's Disease: Analysis of the PPMI Cohort
por: Lee, Jeong Won, et al.
Publicado: (2019)

An Increased Burden of Highly Active Retrotransposition Competent L1s Is Associated with Parkinson’s Disease Risk and Progression in the PPMI Cohort
por: Pfaff, Abigail L., et al.
Publicado: (2020)

The Association of CSF sTREM2 With Cognitive Decline and Its Dynamic Change in Parkinson's Disease: Analysis of the PPMI Cohort
por: Qin, Qixiong, et al.
Publicado: (2022)

Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI
por: Huh, Young Eun, et al.
Publicado: (2021)

MAO-inhibitors in Parkinson's Disease
por: Riederer, Peter, et al.
Publicado: (2011)

Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
por: Simuni, Tanya, et al.
Publicado: (2022)

Predicting miRNA-disease associations based on PPMI and attention network
por: Xie, Xuping, et al.
Publicado: (2023)

Validation of the Parkinson Fatigue Scale in Chinese Parkinson's disease patients
por: Fu, Rao, et al.
Publicado: (2017)

A test-retest study on Parkinson's PPMI dataset yields statistically significant white matter fascicles
por: Cousineau, Martin, et al.
Publicado: (2017)

Methodological considerations of evaluating the rate of presynaptic dopaminergic denervation in Parkinson disease with radiotracers: Analysis of the PPMI data
por: Lee, Jeong Won, et al.
Publicado: (2021)

LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts
por: Merchant, Kalpana M., et al.
Publicado: (2023)

Serial changes of I-123 FP-CIT SPECT binding asymmetry in Parkinson's disease: Analysis of the PPMI data
por: Jeong, Eun Hye, et al.
Publicado: (2022)

Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study
por: Koros, Christos, et al.
Publicado: (2023)

Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson’s disease: Analysis of the PPMI data
por: Lee, Jeong Won, et al.
Publicado: (2021)

The Prejudice towards People with Mental Illness (PPMI) scale: structure and validity
por: Kenny, Amanda, et al.
Publicado: (2018)

Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson’s Disease
por: Dorszewska, Jolanta, et al.
Publicado: (2013)

Maó
por: Quintana, Josep M. (Josep Maria)
Publicado: (1996)

Prevalence and risk factors for depression and anxiety in Chinese patients with Parkinson disease
por: Cui, Shi-Shuang, et al.
Publicado: (2017)

Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
por: Finberg, John P. M., et al.
Publicado: (2016)

Mao : a biography /
por: Terrill, Ross
Publicado: (1981)

Mao Zedong
por: Grimm, Tilemann
Publicado: (1986)

MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology
por: Mallajosyula, Jyothi K., et al.
Publicado: (2008)

Rasagiline – a novel MAO B inhibitor in Parkinson’s disease therapy
por: Lecht, Shimon, et al.
Publicado: (2007)

A critical appraisal of MAO-B inhibitors in the treatment of Parkinson’s disease
por: Jost, Wolfgang H.
Publicado: (2022)

Correction: MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology
por: Mallajosyula, Jyothi K., et al.
Publicado: (2012)

Effects of combined MAO-B inhibitors and levodopa vs. monotherapy in Parkinson’s disease
por: Krishna, Rakhee, et al.
Publicado: (2014)

Clinical benefit of MAO-B and COMT inhibition in Parkinson’s disease: practical considerations
por: Regensburger, Martin, et al.
Publicado: (2023)

Mao Tse-Tung
por: Payne, Robert
Publicado: (1972)

Mao Tse-tung
por: MacGregor-hastie, Roy

Reversible Small Molecule Inhibitors of MAO A and MAO B with Anilide Motifs
por: Hagenow, Jens, et al.
Publicado: (2020)

Mutation Analysis of HTRA2 Gene in Chinese Familial Essential Tremor and Familial Parkinson's Disease
por: He, Ya-Chao, et al.
Publicado: (2017)

Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers
por: Ma, Ling-Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dei8sh59l7s1rmt7mpduuchql0